DK118301B - Fremgangsmåde til fremstilling af antitussive præparater, som indeholder dextromethorphan eller et salt deraf. - Google Patents

Fremgangsmåde til fremstilling af antitussive præparater, som indeholder dextromethorphan eller et salt deraf.

Info

Publication number
DK118301B
DK118301B DK22367AA DK22367A DK118301B DK 118301 B DK118301 B DK 118301B DK 22367A A DK22367A A DK 22367AA DK 22367 A DK22367 A DK 22367A DK 118301 B DK118301 B DK 118301B
Authority
DK
Denmark
Prior art keywords
salt
preparation
compositions containing
containing dextromethorphan
antitussive compositions
Prior art date
Application number
DK22367AA
Other languages
English (en)
Inventor
R Barry
M Weiss
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of DK118301B publication Critical patent/DK118301B/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK22367AA 1966-01-13 1967-01-13 Fremgangsmåde til fremstilling af antitussive præparater, som indeholder dextromethorphan eller et salt deraf. DK118301B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52036966A 1966-01-13 1966-01-13

Publications (1)

Publication Number Publication Date
DK118301B true DK118301B (da) 1970-08-03

Family

ID=24072303

Family Applications (1)

Application Number Title Priority Date Filing Date
DK22367AA DK118301B (da) 1966-01-13 1967-01-13 Fremgangsmåde til fremstilling af antitussive præparater, som indeholder dextromethorphan eller et salt deraf.

Country Status (10)

Country Link
US (1) US3427379A (da)
BE (1) BE692250A (da)
DE (1) DE1617515A1 (da)
DK (1) DK118301B (da)
ES (1) ES335565A1 (da)
FR (1) FR6250M (da)
GB (1) GB1111173A (da)
IL (1) IL27056A (da)
NL (1) NL6700549A (da)
SE (1) SE338401B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3903284A (en) * 1971-10-06 1975-09-02 Denson Fred L Composition containing iminoethanophenanthrene derivatives and method of use
US4316888A (en) * 1980-04-15 1982-02-23 Nelson Research & Development Co. Method and composition of reducing pain
US4971798A (en) * 1989-11-30 1990-11-20 Miles Inc. Hard confections containing hydrogenated isomaltulose and medicinally active ingredient
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
GB2257363B (en) * 1991-01-30 1994-09-28 Wellcome Found Water dispersible tablets containing acyclovir
US5302394A (en) * 1992-07-14 1994-04-12 Mcneil-Ppc, Inc. Dextromethorphan continuous lozenge manufacturing process
GB9215908D0 (en) * 1992-07-27 1992-09-09 Wellcome Found Water dispersible tablets
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
US5622980A (en) * 1993-08-17 1997-04-22 Applied Analytical Industries, Inc. Oral compositions of H2-antagonists
US8425892B2 (en) 2001-10-29 2013-04-23 Columbia Laboratories, Inc. Extended, controlled-release pharmaceutical compositions using charged polymers
US20050238695A1 (en) * 2004-04-27 2005-10-27 Atma Chaudhari Lozenge for delivery of dextromethorphan
US8668902B2 (en) * 2006-06-08 2014-03-11 Vapor Shield, Inc. Composition with activated carbon in oral treatment

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3123528A (en) * 1964-03-03 New therapeutic compositions
US2841528A (en) * 1954-09-21 1958-07-01 Collett & Co As Method of making fused tablets
US2963404A (en) * 1958-09-05 1960-12-06 Pfizer & Co C Tannate candy making, and product
US3012893A (en) * 1959-01-06 1961-12-12 Gen Foods Corp Gasified confection and method of making the same
NL272604A (da) * 1960-12-28
US3140978A (en) * 1961-11-02 1964-07-14 Hoffmann La Roche Pharmaceutical composition containing complex magnesium aluminum silicate
US3248290A (en) * 1962-08-09 1966-04-26 Hoffmann La Roche Antitussive compositions
US3282789A (en) * 1963-05-17 1966-11-01 Neisler Lab Inc Stable liquid colloidal tannate compositions
US3341414A (en) * 1964-08-27 1967-09-12 Merck & Co Inc N-cyclohexylsulfamate solubilized medication

Also Published As

Publication number Publication date
GB1111173A (en) 1968-04-24
ES335565A1 (es) 1968-03-16
IL27056A (en) 1970-07-19
FR6250M (da) 1968-08-19
US3427379A (en) 1969-02-11
SE338401B (da) 1971-09-06
NL6700549A (da) 1967-07-14
DE1617515A1 (de) 1971-03-18
BE692250A (da) 1967-07-06

Similar Documents

Publication Publication Date Title
DK115473B (da) Fremgangsmåde til fremstilling af 2,3,4,5-tetrahydro-1H-3-benzazepiner eller syreadditionssalte deraf.
DK130070B (da) Analogifremgangsmåde til fremstilling af 3,4-dihydroxyphenylalkanolaminer eller syreadditionssalte deraf.
DK134113B (da) Analogifremgangsmåde til fremstilling af 1,2,3,4-tetrahydro-7-halogen-eller 7-trifluormethyl-6-sulfamyl-4-quinazolinoner eller salte heraf.
DK124404B (da) Fremgangsmåde til fremstilling af 2-arylamino-1,3-diazacycloalkener-(2) eller syreadditionssalte deraf.
DK120551B (da) Fremgangsmåde til fremstilling af benzothiophenderivater eller syreadditionssalte heraf.
DK118301B (da) Fremgangsmåde til fremstilling af antitussive præparater, som indeholder dextromethorphan eller et salt deraf.
DK117427B (da) Fremgangsmåde til fremstilling af phenoxypropanolaminer eller syreadditionssalte deraf.
DK129234B (da) Fremgangsmåde til fremstilling af levo-1-n-butyl-2',6'-pipecoloxylidid.
DK123032B (da) Analogifremgangsmåde til fremstilling af 1-phenoxymethyl-3,4-dihydro- og -1,2,3,4-tetrahydro-isoquinolin-forbindelser eller salte deraf.
DK123031B (da) Analogifremgangsmåde til fremstilling af derivater af 1-benzyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolin eller syreadditionssalte deraf.
DK121367B (da) Analogifremgangsmåde til fremstilling af 3,3-difenylallylaminderivater eller syreadditionssalte deraf.
DK129994B (da) Analogifremgangsmåde til fremstilling af 1-trimethoxybenzyl-6,7-dialkanoyl-1,2,3,4-tetrahydroisoquinoliner eller syreadditionssalte deraf.
DK130210B (da) Fremgangsmåde til fremstilling af sulfoniumsalte.
DK119166B (da) Fremgangsmåde til fremstilling af 1,4-bezodiazepinderivater.
DK138740B (da) Fremgangsmåde til fremstilling af 1,4-benzodiazepinderivater eller syreadditionssalte deraf.
DK121125B (da) Fremgangsmåde til fremstilling af 1,4-benzodiazepinderivater eller syreadditionssalte deraf.
DK119826B (da) Fremgangsmåde til fremstilling af α-6-deoxytetracyclin, α-6-deoxy-5-oxytetracyclin eller syreadditionssalte deraf.
DK140591B (da) Analogifremgangsmåde til fremstilling af cyclopeptider eller syreadditionssalte deraf.
DK126936B (da) Fremgangsmåde til fremstilling af 3-oxo-13β-alkylgona-4,9,11-triener.
DK115840B (da) Fremgangsmåde til fremstilling af phenylcyclohexylalkylaminer eller syreadditionssalte deraf.
DK125552B (da) Fremgangsmåde til fremstilling af 1,2,3,4-tetrahydroisoquinolin-2-carboxamidiner eller syreadditionssalte deraf.
DK125083B (da) Fremgangsmåde til fremstilling af 2,3-diklor-4-butyryl-fenoxyeddikesyre.
DK120029B (da) Analogifremgangsmåde til fremstilling af substituerede 3-aminoacylaminothiophener eller salte deraf.
DK121237B (da) Fremgangsmåde til fremstilling af (alkylaminoætoksy)-dihalogenaniliner eller syreadditionssalte deraf.
DK112385B (da) Fremgangsmåde til fremstilling af N-guanyl-3-azabicyclo[3,2,0]heptan-3-carbonxamidin eller syreadditionssalte heraf.